Assessing the Emergence of Resistance: The Absence of Biological Cost In Vivo May Compromise Fosfomycin Treatments for P. aeruginosa Infections.
Saved in:
| Title: | Assessing the Emergence of Resistance: The Absence of Biological Cost In Vivo May Compromise Fosfomycin Treatments for P. aeruginosa Infections. |
|---|---|
| Authors: | Rodríguez-Rojas, Alexandro1 (AUTHOR) arrojas@cnb.csic.es, Maciá, María D.2 (AUTHOR), Couce, Alejandro1 (AUTHOR), Gómez, Cristina3 (AUTHOR), Castañeda-García, Alfredo1 (AUTHOR), Oliver, Antonio2 (AUTHOR), Blázquez, Jesús1 (AUTHOR) blazquez@cnb.csic.es |
| Source: | PLoS ONE. 2010, Vol. 5 Issue 4, p1-9. 9p. 1 Color Photograph, 4 Charts, 4 Graphs. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
